SCHEMBL30349558

SCHEMBL30349558

CCOC(=O)c1cnn2c(NC)cc(Nc3ccccc3OC)nc12

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 15/20 0.61
▸ STAT3 P40763 1/20 0.61
▸ PDE4D Q08499 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ JAK1 P23458 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21811191 1.00 TYK2 (0.61) TYK2STAT3PDE4DSMN1; SMN2MAPT
SCHEMBL21887788 0.92 TYK2 (0.53) TYK2STAT3PDE4DSMN1; SMN2ALOX15
SCHEMBL21887328 0.88 TYK2 (0.66) TYK2STAT3PDE4DJAK1
SCHEMBL21887349 0.86 TYK2 (0.69) TYK2STAT3PDE4DJAK1
SCHEMBL30349340 0.86 ADORA3 (0.48) TYK2STAT3SMN1; SMN2MAPTUSP2
SCHEMBL30349550 0.83 TYK2 (0.60) TYK2STAT3PDE4DMAPT
SCHEMBL21811202 0.83 TYK2 (0.60) TYK2STAT3PDE4DMAPT
SCHEMBL21887357 0.82 TYK2 (0.58) TYK2STAT3PDE4DJAK1
SCHEMBL22343246 0.81 TYK2 (0.49) TYK2PDE4DSMN1; SMN2JAK1KDM4E
SCHEMBL24961657 0.81 TYK2 (0.55) TYK2STAT3PDE4DMAPTJAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112638915-B Pyrazolo [1,5-a ] pyrimidine-3-carboxamide derivatives for the treatment of psoriasis and systemic lupus erythematosus 伊莱利利公司 2023-04-07 — — CN disclosed
Send feedback